ASN Kidney Translation Series: 2026 ASN Journals' Trainees of the Year

This episode of ASN Kidney Translation Podcast, we review 2 late-breaking clinical trials: empagliflozin in ADPKD and upacicalcet for secondary hyperparathyroidism in hemodialysis. The authors discuss efficacy, safety, and implications for kidney practice

ASN Kidney Translation Podcast highlights the 2026 Trainees of the Year: Kidney360 on MRI-based kidney stress testing, CJASN on intratubular cast composition using spatial protein imaging, and JASN on Tenascin C–mediated kidney regeneration in axolotls.

Drs. Ian McCoy and Chi-yuan Hsu discuss their study, "Dialysis Discontinuation Rates at Low Levels of Kidney Function in Patients with Acute Kidney Injury on Intermittent Hemodialysis," with JASN Deputy Editor Manjula Kurella Tamura.

Drs. Chitalia, Almiron, and Sethuraman discuss their study, "Indoxyl Sulfate Promotes Uremic Arterial and Venous Thrombosis by Stabilizing IDO1 via the E3 Ligase SHFM3," with JASN Deputy Editor Alan S.L. Yu and Junior Associate Editor Kyle Jansson.

Drs. Conor Donnelly, Michal A. Mankowski, and Allan B. Massie discuss the findings of their study, "Evaluating Barriers to Kidney Transplantation in the United States," with JASN Deputy Editor David H. Ellison and Junior Associate Editor Nathan H. Raines.

This episode of ASN Kidney Translation Podcast explores the ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic (CKM) Syndrome, discussing key recommendations, risk assessment, and strategies to improve kidney, heart, and metabolic outcomes.

Dr. Oyindamola Christiana Adebayo discusses the results of her study, "Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity," on behalf of her coauthors, with JASN Deputy Editor David H. Ellison.

ASN Kidney Translation explores advances in Cardiovascular-Kidney-Metabolic syndrome, including building a cardio-nephrology service (Kidney360), cardiorenal benefits of SGLT2 inhibitors & GLP-1 receptor agonists (JASN), & PREVENT risk prediction (CJASN).

Dr. Fan-Chi Chang discusses findings from her study, "Cell-Specific Roles of Angiopoietin-2 in CKD," with JASN Deputy Editor Alan S.L. Yu.

Drs. Benjamin Catanese and Daniel Edmonston discuss their study, "Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure," with JASN Deputy Editor Manjula Kurella Tamura.